ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

10 Fibro-Friendly Foods with a Bonus: Beautiful Skin

Fight Back! Win the War Being Waged Against Your Immune System

The role of microbiota and intestinal permeability in the pathophysiology of autoimmune and neuroimm...

Studies Show that Magnesium L-threonate Improves Brain Plasticity, Leading to Direct and Significant...

Clary Sage Oil May Be Pricey, but Its Benefits Are Priceless

Component of red wine, grapes can help to reduce inflammation, study finds

Poly MVA: A Novel Therapy for Increasing Energy, Repairing DNA, and Promoting Overall Health

Acupressure reduced fatigue in breast cancer survivors

Omega-3 fatty acid stops known trigger of lupus

What’s Fenugreek Good For?

Print Page
Email Article

Vaccine Prevents Stroke in Rats

  [ 23 votes ]   [ Discuss This Article ] • September 5, 2002

A vaccine that interferes with inflammation inside blood vessels greatly reduces the frequency and severity of strokes in spontaneously hypertensive, genetically stroke-prone rats, according to a new study from the NIH's National Institute of Neurological Disorders and Stroke (NINDS). If the vaccine works in humans, it could prevent many of the strokes that occur each year.

In the study, researchers used a nasal spray to deliver a protein that, under normal circumstances, contributes to inflammation of the cells that line the inner walls of blood vessels. Exposing rats to this substance, called E-selectin, programs blood cells called lymphocytes to monitor the blood vessel lining for the inflammatory protein. When these lymphocytes detect E-selectin, they produce substances that suppress inflammation.

The vaccine is the first treatment to target inflammation in blood vessels as a possible means of preventing stroke, says senior author John M. Hallenbeck, M.D., chief of the Stroke Branch at NINDS. "Clinically, stroke is hard to treat. If we can prevent it from happening, that's clearly the way to go," he adds. The study appears in the September 2002 issue of the journal Stroke.*

Stroke is the third leading cause of death in the United States and the most common cause of disability in adults. Each year more than 500,000 Americans have a stroke, and about 150,000 die from stroke-related causes. A stroke occurs when the blood supply to the brain is suddenly interrupted, as with a blood clot (ischemic stroke), or when a blood vessel in the brain bursts, spilling blood into the spaces surrounding brain cells (hemorrhagic stroke). Current stroke prevention strategies include reducing risk factors, such as high blood pressure (hypertension), or blocking the formation of blood clots using drugs such as aspirin and warfarin.

Animal studies have shown that blood vessels undergo periodic cycles of inflammation. These cycles are more frequent and intense in stroke-prone animals. In rats with stroke risk factors, such as hypertension, diabetes, or advanced age, a single dose of a substance found in bacteria can provoke inflammation that leads to a blood clot or a blood vessel hemorrhage. Researchers believe inflammation also contributes to stroke in humans.

In the new study, Dr. Hallenbeck and colleagues tested human E-selectin and two other substances (used as controls) in a total of 113 stroke-prone rats with genetically induced hypertension. Some of the rats received a single course of E-selectin every other day for 10 days, while others received the 10-day course of treatment every 3 weeks until they died or until the study was complete.

The results of the investigation were dramatic. During more than a year of study, the rats that received repeated E-selectin vaccine treatment had 16 times fewer ischemic strokes than those given repeated treatment with a control substance. Furthermore, none of the rats given repeated vaccine treatment had a hemorrhagic stroke, while the other groups had two to three hemorrhagic strokes on average during the study period. Strokes that did occur in the rats with repeated vaccine treatment caused much less brain damage than strokes in the control rats. The researchers also found that lymphocytes from rats treated with the E-selectin vaccine produced a type of chemical called a cytokine that blocked inflammation in blood vessels.

The single course of vaccine treatment did not maintain the animals' resistance to stroke; repeated treatment with the vaccine was required for long-term stroke prevention, the researchers say.

The vaccine did not have any effect on the rats' blood pressure. This shows that its beneficial effects are not linked to reduction of high blood pressure, a proven means of reducing the risk of stroke, Dr. Hallenbeck notes. If the vaccine proves effective in people, it would be used in conjunction with control of high blood pressure and other risk factors, he adds.

"We think the E-selectin vaccine works by reducing immune and inflammatory reactions in vessels that threaten either to become blocked or to rupture and bleed," Dr. Hallenbeck says. This contrasts with many other vaccines, such as flu shots, which work by increasing the immune system's reactions to specific viruses or bacteria.

The researchers are now planning a Phase I clinical trial to test the effects of human and bovine E-selectin vaccines in people at high risk for stroke. That trial will study whether the vaccines are safe to use in people and what the side effects may be. The bovine E-selectin will be tested in addition to the human protein because there is a chance it may produce a stronger response, Dr. Hallenbeck says. The two vaccines are being produced by Novavax, Inc., of Columbia, Maryland, under a Cooperative Research and Development Agreement (CRADA) with NINDS.

The NINDS is a component of the National Institutes of Health in Bethesda, Maryland, and is the nation's primary supporter of biomedical research on the brain and nervous system.

*Takeda H, Spatz M, Ruetzler C, McCarron R, Becker K, Hallenbeck J. "Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats." Stroke: Journal of the American Heart Association, Vol. 33, No. 9, September 2002, pp. 2156-2164.

Post a Comment

Featured Products From the ProHealth Store
Energy NADH™ 12.5mg Ultra ATP+, Double Strength Optimized Curcumin Longvida®

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

Natural Pain Relief Supplements

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Optimize Your Immune System Naturally: Thymic Protein A Optimize Your Immune System Naturally: Thymic Protein A
Itching to Find Dry Skin Relief? Itching to Find Dry Skin Relief?
Physically and Mentally Exhausted? How to Restore Energy at Its Source Physically and Mentally Exhausted? How to Restore Energy at Its Source
Strontium - The Missing Mineral for Strong Bones Strontium - The Missing Mineral for Strong Bones
Fight Inflammation and Promote Cognitive Health with High-OPC Grape Seed Fight Inflammation and Promote Cognitive Health with High-OPC Grape Seed

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map